Login
English
Nederlands
Fin. & Econ. Org. of Healthcare Markets
| Faculteit | Economie en Bedrijfskunde |
| Jaar | 2022/23 |
| Vakcode | EBM194A05 |
| Vaknaam | Fin. & Econ. Org. of Healthcare Markets |
| Niveau(s) | master, uitwisseling |
| Voertaal | Engels |
| Periode | semester II a |
| ECTS | 5 |
| Rooster | rooster |
| Uitgebreide vaknaam | Financial and Economic Organization of Healthcare Markets | ||||||||||||||||||||||||||||||||||||||||||||
| Leerdoelen | After completion of this course in health economics you are able to: 1. Explain and evaluate the economics behind health insurance, from an individual, firm and societal perspective. 2. Outline, and explain possible reactions to, incentives faced by physicians, hospitals, and the pharmaceutical industry. 3. Discuss how regulation can and should affect incentives faced by these actors. 4. Outline how the pharmaceutical industry carries out and makes decisions regarding research and development. |
||||||||||||||||||||||||||||||||||||||||||||
| Omschrijving | This course incorporates an advanced perspective on the economics behind organizations operating in the health and healthcare sectors. We recap the individual decision to buy health insurance and discuss the social benefits and costs arising from its provision. We explain why health insurance markets may fail, and solutions that may arise to obviate such market failure. We then discuss major actors in health and healthcare markets: physicians, hospitals, and the pharmaceutical industry. We examine how principal-agent problems characterize the patient-physician relationship. We examine funding methods for hospitals and their impact on physician's incentives. We finally examine the role of the pharmaceutical industry in researching and developing new health technologies and treatments, as well as the process of getting drugs to market. | ||||||||||||||||||||||||||||||||||||||||||||
| Uren per week | 4 | ||||||||||||||||||||||||||||||||||||||||||||
| Onderwijsvorm |
-hoorcollege , -werkcollege
(and seminars) |
||||||||||||||||||||||||||||||||||||||||||||
| Toetsvorm | -groepsopdracht, -schriftelijk tentamen (open vragen) | ||||||||||||||||||||||||||||||||||||||||||||
| Vaksoort | master | ||||||||||||||||||||||||||||||||||||||||||||
| Coördinator | Dr. A. Bergemann | ||||||||||||||||||||||||||||||||||||||||||||
| Docent(en) | Dr. A. Bergemann , H.H. Dijk, PhD. | ||||||||||||||||||||||||||||||||||||||||||||
| Verplichte literatuur |
|
||||||||||||||||||||||||||||||||||||||||||||
| Entreevoorwaarden | |||||||||||||||||||||||||||||||||||||||||||||
| Opmerkingen | Secretary: Kim Beute, phone: +31(0)50 36 37018, e-mail: k.beute@rug.nl, room 5411.0734. | ||||||||||||||||||||||||||||||||||||||||||||
| Opgenomen in |
|